Conference abstract · 1 Apr 2019
EditorialPublished 28 Mar 2022
To Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
Keywords
Subjects
Pharmaceutical SciencesSimilar by topic
Perspective · 28 Mar 2022
To Assess the Cost and Resource Use Associated with Spinal Muscular Atrophy Management
Conference abstract · 18 Mar 2019
Assessment of awareness of the early clinical features of Spinal Muscular Atrophy (SMA) amongst pediatricians
Review article · 3 May 2019
SMN2 Gene Based Treatments In Spinal Muscular Atrophy- A Review Of Recent Advancements
Opinion · 29 Mar 2022
What is SMA (spinal muscular atrophy) in children?
More from this journal
The newest in Pharmacoeconomics: Open Access.
Opinion · 1 Dec 2025
Drug Repurposing: Economic Gains, Faster Pathways, Rare Diseases
Short communication · 1 Dec 2025
Preventive Drugs for Older Adults: Health and Economic Benefits
Brief report · 29 Nov 2025
Value Assessment Of High-cost Specialty Drugs
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmacoeconomics: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Patrich J. Welch”

